Search

everythinglearnresearchcommunity

for

Search:↓

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

New compounds may soon be tested to treat excessive hair growth in women.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

DHT may increase the risk of heart disease and death in elderly men.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Neurosteroids show promise for treating epilepsy and more research is needed.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

FLRG and follistatin have different roles in wound healing.